首页 > 市场调查报告书 > 医疗设备

医学影像诊断药物递输设备电子医疗设备内视镜检查设备

智慧药丸市场规模、份额和成长分析（按目标领域、应用、疾病适应症、最终用户和地区划分）—2026-2033年产业预测

市场调查报告书

商品编码

1898481

智慧药丸市场规模、份额和成长分析（按目标领域、应用、疾病适应症、最终用户和地区划分）—2026-2033年产业预测

Smart Pills Market Size, Share, and Growth Analysis, By Target Area (Small Intestine, Large Intestine), By Application (Capsule Endoscopy, Patient Monitoring), By Disease Indication, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月25日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，智慧药丸市场规模将达到 11.1 亿美元，到 2025 年将达到 12.4 亿美元，到 2033 年将达到 29.1 亿美元，在预测期（2026-2033 年）内，复合年增长率为 11.3%。

市场趋势表明，智慧药丸市场正经历强劲成长，这主要得益于慢性病盛行率的上升以及患者对提高用药依从性的需求。心臟病和糖尿病等慢性病需要严格的治疗方案，但依从性差往往会导致健康恶化和医疗成本增加。智慧药丸配备感测器、微晶片和无线通讯功能，能够提供即时剂量和依从性数据，从而简化药物管理并加强患者与医疗专业人员之间的协作。有利的报销模式、对微创手术的需求以及内视镜技术的进步正在推动市场进一步扩张。人工智慧与智慧药丸技术的协同作用增强了数据分析能力，从而实现早期诊断、个人化治疗和有效预防策略，满足了对创新医疗解决方案的迫切需求。

智慧药丸市场驱动因素

数位科技在医疗保健领域的融合是智慧药丸市场成长的主要驱动力。随着以患者为中心的护理和持续健康监测需求的不断增长，智慧药物提供了创新解决方案，不仅能够提高患者的用药依从性，还能实现即时数据追踪。这些先进药物的关键优势之一在于，它们能够将包括pH值、温度和各种生理参数在内的关键劣化数据直接传输给医疗服务提供者。这项功能增强了病患监测，提高了用药依从性，并最大限度地减少了药物滥用。因此，个人化精准医疗的趋势正在推动医疗专业人员对智慧药物解决方案的投资和应用，这与整体转型为数位医疗创新的趋势不谋而合。

智慧药丸市场的限制

智慧药丸市场面临许多挑战，其中高成本阻碍了其广泛普及。这些设备所需的尖端技术，例如感测器、微晶片和无线电发送器，推高了製造成本，使得许多潜在用户难以负担。在医疗预算有限的中低收入社区，这一障碍尤为突出。此外，缺乏针对智慧药丸等数位健康技术的明确报销政策，也为医疗服务提供者和保险公司带来了额外的障碍，使得这些创新难以融入日常医疗实践，并限制了最需要受益人群的取得。

智慧药丸市场趋势

智慧药丸市场正经历一场重大变革时期，微型感测器技术的进步将推动更有效率、更先进的药物传递系统的发展。这些现代智慧药丸配备了微型感测器，能够收集包括肠蠕动、酸度水平和即时药物吸收指标在内的多种胃肠道数据。因此，智慧药丸正日益成为一种自主工具，在个人化医疗和行为管理中发挥关键作用。这项发展不仅提高了患者的用药依从性和疗效，也为创新疗法铺平了道路，反映了医疗保健领域对智慧药物解决方案日益增长的需求。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

Medtronic PLC（Ireland）
Proteus Digital Health Inc.（US）
CapsoVision Inc.（US）
Olympus Corporation（Japan）
Medisafe（US）
Bio-Images Research Limited（UK）
BodyCap（France）
Philips Healthcare（Netherlands）
Medimetrics Personalized Drug Delivery BV（Netherlands）
PENTAX Medical（Japan）
Proteus Biomedical（US）
Check-Cap Ltd.（Israel）
IntroMedic Co. Ltd.（South Korea）

结论与建议

简介目录

Product Code: SQMIG35I2313

Smart Pills Market size was valued at USD 1.11 Billion in 2024 and is poised to grow from USD 1.24 Billion in 2025 to USD 2.91 Billion by 2033, growing at a CAGR of 11.3% during the forecast period (2026-2033).

Market insights indicate that the smart pills sector is experiencing robust growth, fueled by the rising incidence of chronic diseases and the demand for enhanced medication adherence. Chronic conditions like heart disease and diabetes necessitate strict treatment regimens, often leading to poor health outcomes and increased healthcare costs due to non-compliance. Smart pills, equipped with sensors, microchips, and wireless communication, facilitate medication tracking and improve patient-clinician interactions by providing real-time data on dosage and treatment adherence. Factors such as favorable reimbursement models, the demand for minimally invasive procedures, and advancements in endoscopy techniques are further propelling market expansion. The synergy of artificial intelligence with smart pill technology is enhancing data analytics, enabling early diagnosis, tailored treatments, and effective prevention strategies, meeting the urgent need for innovative healthcare solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Smart Pills market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Smart Pills Market Segments Analysis

Global Smart Pills Market is segmented by Target Area, Application, Disease Indication, End User and region. Based on Target Area, the market is segmented into Small Intestine, Large Intestine, Esophagus and Stomach. Based on Application, the market is segmented into Capsule Endoscopy, Patient Monitoring and Targeted Drug Delivery. Based on Disease Indication, the market is segmented into Occult Gi Bleeding, Crohn's Disease, Small Bowel Tumors, Celiac Disease and Other Disease Indications. Based on End User, the market is segmented into Hospitals, Diagnostic Centers, Outpatient Settings (Clinics, Ambulatory Care Centers) and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Smart Pills Market

The integration of digital technologies in healthcare significantly drives the growth of the smart pills market. As the demand for patient-centered care and continuous health monitoring rises, smart medications present innovative solutions that enhance medication adherence while enabling real-time data tracking. One of the key benefits of these advanced medications is their ability to send critical degradation data, including pH levels, temperature, and various physiological parameters, directly to healthcare providers. This capability enhances patient monitoring, boosts compliance, and minimizes medication errors. Consequently, the trend toward personalized precision medicine is prompting healthcare professionals to invest in and embrace smart pharmaceutical solutions, aligning with the overall shift towards digital health innovations.

Restraints in the Smart Pills Market

The Smart Pills market faces significant challenges due to high costs, which hinder widespread adoption. The advanced technology needed for these devices, including sensors, microchips, and wireless transmitters, drives up manufacturing expenses, making them financially inaccessible for many potential users. This barrier is particularly pronounced in low- and middle-income regions, where healthcare budgets are limited. Additionally, the absence of well-defined reimbursement policies for digital health technologies, such as smart pills, creates further obstacles for healthcare providers and insurers, complicating the integration of these innovations into regular healthcare practices and limiting their availability to those who could benefit most.

Market Trends of the Smart Pills Market

The Smart Pills market is experiencing a significant transformation driven by advancements in micro-sensor technology, resulting in more efficient and sophisticated drug delivery systems. These modern smart pills incorporate miniaturized sensors that enable the collection of extensive gastrointestinal data, such as motility, acid levels, and real-time drug absorption metrics. As a result, they are increasingly positioned as autonomous tools that play a crucial role in personalized healthcare and behavioral management. This evolution not only enhances medication adherence and efficacy but also paves the way for innovative treatment approaches, reflecting a growing demand for smart medication solutions in the healthcare sector.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Patent Analysis
Technology Analysis
Case Studies
Customer And Buying Criteria Analysis

Global Smart Pills Market Size by Target Area & CAGR (2026-2033)

Market Overview
Small Intestine
Large Intestine
Esophagus
Stomach

Global Smart Pills Market Size by Application & CAGR (2026-2033)

Market Overview
Capsule Endoscopy
Patient Monitoring
Targeted Drug Delivery

Global Smart Pills Market Size by Disease Indication & CAGR (2026-2033)

Market Overview
Occult Gi Bleeding
Crohn's Disease
Small Bowel Tumors
Celiac Disease
Other Disease Indications

Global Smart Pills Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Diagnostic Centers
Outpatient Settings (Clinics, Ambulatory Care Centers)
Other End Users

Global Smart Pills Market Size & CAGR (2026-2033)

North America (Target Area, Application, Disease Indication, End User)
- US
- Canada
Europe (Target Area, Application, Disease Indication, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Target Area, Application, Disease Indication, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Target Area, Application, Disease Indication, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Target Area, Application, Disease Indication, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Medtronic PLC (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Proteus Digital Health Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CapsoVision Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medisafe (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Images Research Limited (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BodyCap (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips Healthcare (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medimetrics Personalized Drug Delivery B.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PENTAX Medical (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Proteus Biomedical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Check-Cap Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IntroMedic Co. Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments